Treatment failure with ciprofloxacin has been reported for isolates with MIC's > 0.05 mg/l.' The mechanism of quinolone resistance in gonococci has recently been shown to be due to mutations in the gyrA gene analagous to the mutations that occur in Escherichia coli and Staphylococcus aureus2 suggesting that there is potential for very high levels of ciprofloxacin resistance in gonococci. We describe two unrelated cases of ciprofloxacin resistant gonococcal infection occurring in the first six months of 1995: the first case was associated with the development of symptoms following treatment with ciprofloxacin; and the second exhibited extremely high level ciprofloxacin resistance (MIC 16 mg/l) similar to the levels of resistance found in Enterobacteriaceae.
A (Brazil) .
The development of a symptomatic infection following unsuccessful treatment of an asymptomatic infection may have resulted from the growth of large numbers of ciprofloxacin resistant bacteria from a mixed pre-treatment population which comprised both susceptible and resistant variants.
The second case involved a 21 year old Caucasian woman who presented to the GUM department with a contact slip from her husband who had been diagnosed as having gonorrhoea at a military hospital in England. She denied any other contacts in the previous three years. She had noticed an increase in vaginal discharge over the previous two weeks but had attributed this to the fact that she was 27 weeks pregnant. On examination, a thick mucopurulent vaginal discharge was noted. Characteristic gram negative diplococci were not noted on microscopy of vaginal, cervical or urethral smears, but epidemiological treatment with a seven day course of amoxycillin was instituted at her initial attendance. N gonorrhoeae was cultured from the urethra, endocervix and rectum and we were notified that the strain was penicillinase producing prior to full antibiotic sensitivities being available. By liaising with the referring clinic it was ascertained that her husband's gonococcal strain was also resistant to ciprofloxacin. In view of the multiple antibiotic resistance, and the patient's pregnancy, she was treated with spectinomycin 2 g im. Repeat gonococcal cultures one and two weeks later were all negative.
The isolate was forwarded to the SNGRL and confirmed as a PPNG isolate of serovar IB 1, auxotype non requiring, resistant to ciprofloxacin (MIC 16 mg/l), of intermediate sensitivity to cefuroxime (MIC 0.50 mg/l), tetracycline (MIC 1.0 mg/l), erythromycin (MIC 2.00 mg/l), but fully sensitive to spectinomycin (MIC < 16 mg/l). The isolate carried a 3.05 MDa resistance plasmid as well as the 24.5 MDa transfer and 2.6 MDa cryptic plasmids.
Overall the prevalence of ciprofloxacin resistance (defined by an MIC > 0.05 mg/l) is low in Scotland and was found in only 1.3% (25/1960) of all isolates tested by the SNGRL between 1991 and 1994. The prevalence of ciprofloxacin resistance for the serovars described in this report was 1 6% (2/123) for IB3 (both non-PPNG isolates) and 8-5% (11/130) for IB1 (7 PPNG isolates). The actual level of ciprofloxacin resistance also tended to be low: the MIC of the 25 strains were 0-064 mg/l (4 strains); 0K125 mg/l (6 strains); 0-25 mg/l (7 strains); 0.50 mg/l (7 strains), and 2-0 mg/l (1 strain). 
